XM does not provide services to residents of the United States of America.

European shares ease after Fed decision, mixed earnings



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 2-European shares ease after Fed decision, mixed earnings</title></head><body>

For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.

ING jumps on new share buyback, strong Q1

Novo Nordisk slides as obesity drug concerns weigh

Hugo Boss shares fall on weaker China demand, US uncertainty

EZ factory activity took turn for the worse in April- PMI

STOXX down 0.2%

Updated at 1600 GMT

By Ankika Biswas and Johann M Cherian

May 2 (Reuters) -European shares fell slightly in their first May trading session on Thursday as investors returned from a mid-week holiday to gauge a slew of earnings after the Federal Reserve signalled a delay in U.S. interest rate cuts.

The pan-European STOXX 600 .STOXX eased 0.2% after logging its first monthly decline this year in April.

Market sentiment has cooled as investors navigate risks surrounding the Middle East conflict, the European Central Bank's policy outlook beyond June, and the corporate earnings season.

European equities were closed due to the Labour Day holiday on Wednesday, a day that saw the U.S. Fed signal rates would stay higher for longer owing to recent disappointing inflation readings.

"Powell noted the uncertain path forward for U.S. inflation, our base case remains that inflation and economic growth will cool off, allowing the Fed to begin cutting rates in September," UBS analysts said in a note.

While investors are widely confident of an ECB interest rate cut in June, there is still a touch of uncertainty about the path beyond that.

On the earnings front, Danish drugmaker Novo Nordisk NOVOb.CO raised its 2024 outlook as it races to boost output of its Wegovy weight-loss treatment. But competition from rival Eli Lilly LLY.N forced the company to cut prices of the drug, knocking its shares nearly 3% lower.

The drugmaker weighed on Copenhagen's OMX 20 index .OMXC20, while the broader healthcare sector .SXDP lost 0.7%.

Netherlands' ING Groep INGA.AS rose 6.4% after announcing a 2.5-billion-euro ($2.68 billion) share buyback and a strong first-quarter performance, while Britain's Standard Chartered STAN.L jumped 8.8% following a first-quarter profit beat, putting the banking index .SX7P among top gaining sectors.

Hugo Boss BOSSn.DE was the STOXX's biggest loser, down nearly 10% after the premium apparel brand flagged weaker demand in China and concern about U.S. consumer sentiment ahead of the presidential election.

Of the 136 companies on the STOXX 600 to have reported earnings to date, 58.8% have exceeded analyst estimates, compared with a long term average of 54%, according to weekly LSEG data released on Tuesday.

Danish shipping giant Maersk MAERSKb.CO dropped 4.4% after a first-quarter earnings miss, while French office services and call centre company Teleperformance TEPRF.PA was up 13.8% on higher first-quarter sales.

Danish hearing-aid company GN Store Nord GN.CO rose 11.9% after better-than-expected first-quarter earnings.

Meanwhile, a survey showed the ongoing downturn in euro zone manufacturing activity deepened in April, pushing firms to reduce headcount again.



Reporting by Ankika Biswas and Johann M Cherian in Bengaluru; Editing by Sonia Cheema and Sherry Jacob-Phillips, Kirsten Donovan

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.